SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-24-104564
Filing Date
2024-12-02
Accepted
2024-12-02 16:15:10
Documents
2
Period of Report
2024-11-22

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 5402
2 POWER OF ATTORNEY ea022337401ex24-1_enzo.htm EX-24 4121
  Complete submission text file 0001213900-24-104564.txt   10951
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Issuer) CIK: 0000316253 (see all company filings)

IRS No.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)

Mailing Address 630 FIFTH AVENUE SUITE 2260 NEW YORK NY 10020
Business Address
COUCHMAN JONATHAN (Reporting) CIK: 0001265094 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-09974 | Film No.: 241519206